2022年6月博士毕业于463永利官网，中美联合培养博士。2022年10月加入463永利官网生物医学工程研究室。作为负责人主持国家自然科学基金青年项目1项，省部级科研项目3项，校/院级项目各1项，参研国家自然科学基金面上项目2项，四川省自然科学基金项目2项。以第一/共一作者在Biomaterials、Theranostcis、Bone Research、Genes Dis、 Regen Biomater等期刊发表论文10余篇，授权专利2项。

研究方向：

心脑血管疾病的力学发病机制及药物递送治疗

代表性论文（#为共同一作）

1. Fei Fang, et al., Xiaoheng Liu*. Macrophage-based pathogenesis and theranostics of vulnerable plaques. Theranostics, 2025, 15(4):1570-1588. (IF: 12.4)

2. Chunli Li^#, Fei Fang^#, et al., Zhen Zhang*, Xiaoheng Liu*. Engineering extracellular vesicles derived from endothelial cells sheared by laminar flow for anti-atherosclerotic therapy through reprogramming macrophage. Biomaterials, 2025, 314: 122832. (IF: 12.8)

3. Fei Fang, et al., Xiaoheng Liu* & Chenchen Zhou*. The role and applications of extracellular vesicles in osteoporosis. Bone Research, 2024, 12: 4. (IF: 14.3，ESI高被引)

4. Fei Fang, et al., Jing Xie*, Xiaoheng Liu*. Injectable Alginate-Based Hydrogels Encapsulating Engineered Endothelial Extracellular Vesicles for the Treatment of Critical Limb Ischemia. Biomacromolecules, 2024, 25(10): 6656-6665. (IF: 5.5)

5. Fei Fang, et al., Yang Shen*, Xiaoheng Liu*. Cathepsin K Contributed to Disturbed Flow-induced Atherosclerosis is Dependent on Integrin-actin Cytoskeleton-NF-κB Pathway. Genes & Diseases, 2023, 10(2): 583-595. (IF: 6.9)

6. Fei Fang, et al., Xiaoheng Liu*, Song Li*. Tuning Macrophages for Atherosclerosis Treatment. Regenerative Biomaterials, 2023, 10:rabc103. (IF: 5.6)

7. Fei Fang, et al., Song Li*, Yang Shen* and Xiaoheng Liu*. Inflammatory Endothelium-targeted and Cathepsin Responsive Nanoparticles are Effective Against Atherosclerosis. Theranostics,2022,12(9): 4200-4220. (IF: 12.4，封面文章)

8. Wei Tang#, Fei Fang#, Ke Liu#, et al.,Yazhou Wang*. Aligned Biofunctional Electrospun PLGA-LysoGM1 Scaffold for Traumatic Brain Injury Repair. ACS Biomaterials Science & Engineering, 2020, 6(4). (IF: 5.4)

9. Fei Fang, et al., Yazhou Wang*. Non-invasive Approaches for Drug Delivery to the Brain Based on the Receptor Mediated Transport. Materials Science and Engineering: C, 2017, 76(1): 1316-1327 (IF: 8.1)

10. Tiantian Li, Fei Fang, et al., Guixue Wang*, Weihong He*, Xiaoheng Liu*. EGCG alleviates vascular calcification via the MAPK/JunB signaling pathway. Genes & Diseases, 2025, 12(1): 101237. (IF: 6.9)

主持项目

1. 国家自然科学基金青年项目（32301089），30万，2024.1-2026.12，项目负责人。

2. 四川自然科学基金青年项目（2024NSFSC1703），10万，2024.1-2025.12，项目负责人。

3. 四川省博士后科研项目特别资助，5万，项目负责人。

4. 国家博士后基金面上项目（2023M742454），8万，项目负责人。

5. 永利463官网专职博士后研发基金（2023SCU12035），15万，2023.1-2024.12，项目负责人。

6. 463永利官网专职博士后启动基金，15万，2023.1-2024.12，项目负责人。